Source: Wired
Caltech’s BCI trial has moved beyond cursor control and communication into creative expression—Galen Buckwalter can now produce musical tones directly from neural signals, a practical demonstration that brain-computer interfaces must deliver genuine pleasure, not just function, to justify the surgical risks and maintenance burden they impose. Early users won’t tolerate devices that merely restore lost capability if competitors offer richer experiences, so the technology’s viability depends on expanding into domains (music, art, gaming) where healthy people might voluntarily adopt implants. Whoever cracks the “enjoyable BCI” problem first will own the consumer market, not just the medical one.